[New anti-osteoporotic drugs under development]
Abstract:
Cathepsin K is a cysteine protease indispensable for collagen degradation and bone resorption by osteoclasts. Cathepsin K inhibitors suppress bone resorption while keeping osteoclasts alive, which is believed to maintain osteoblast-stimulating activity of osteoclasts. Sclerostin is an osteocyte-derived soluble factor that inhibits the Wnt canonical pathway. Neutralizing antibody against sclerostin strongly but transiently stimulates bone formation. This review will discuss unique actions on bone metabolism and clinical efficacy of these two anti-osteoporotic drugs under development.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Geriatric Patients

